Stephen W. Olson

1.5k total citations
34 papers, 1.0k citations indexed

About

Stephen W. Olson is a scholar working on Nephrology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Stephen W. Olson has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 8 papers in Pathology and Forensic Medicine and 8 papers in Immunology. Recurrent topics in Stephen W. Olson's work include Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Stephen W. Olson is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Vasculitis and related conditions (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Stephen W. Olson collaborates with scholars based in United States, France and Germany. Stephen W. Olson's co-authors include Kevin C. Abbott, Thomas P. Baker, Glenn Wortmann, Kristopher Paolino, Julie A. Ake, Robert Neff, Amy Weintrob, Joshua D. Hartzell, Robin Howard and Christina M. Yuan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stephen W. Olson

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen W. Olson United States 16 298 243 211 198 193 34 1.0k
Yong‐Kwei Tsau Taiwan 20 246 0.8× 45 0.2× 261 1.2× 402 2.0× 88 0.5× 85 1.3k
Anna Manonelles Spain 16 227 0.8× 33 0.1× 101 0.5× 307 1.6× 48 0.2× 52 974
E. Schulz Germany 14 75 0.3× 46 0.2× 72 0.3× 267 1.3× 132 0.7× 72 925
Angela Aggrey United States 7 26 0.1× 271 1.1× 69 0.3× 194 1.0× 217 1.1× 8 1.1k
Mesı̇ha Ekı̇m Türkiye 19 283 0.9× 54 0.2× 192 0.9× 193 1.0× 10 0.1× 52 1.4k
Robert Thoburn United States 13 82 0.3× 28 0.1× 71 0.3× 191 1.0× 106 0.5× 16 1.2k
Saveria Capria Italy 19 22 0.1× 84 0.3× 122 0.6× 278 1.4× 37 0.2× 70 1.3k
Francesc Fernández‐Avilés Spain 24 32 0.1× 57 0.2× 95 0.5× 337 1.7× 70 0.4× 89 1.8k
Kang‐Moon Lee South Korea 27 31 0.1× 40 0.2× 412 2.0× 837 4.2× 42 0.2× 173 2.4k
Olivier Lortholary France 12 69 0.2× 32 0.1× 631 3.0× 184 0.9× 113 0.6× 20 1.0k

Countries citing papers authored by Stephen W. Olson

Since Specialization
Citations

This map shows the geographic impact of Stephen W. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen W. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen W. Olson more than expected).

Fields of papers citing papers by Stephen W. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen W. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen W. Olson. The network helps show where Stephen W. Olson may publish in the future.

Co-authorship network of co-authors of Stephen W. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen W. Olson. A scholar is included among the top collaborators of Stephen W. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen W. Olson. Stephen W. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Olson, Stephen W., Leila C. Sahni, Natasha Halasa, et al.. (2024). Effectiveness of Maternal Influenza Vaccination During Pregnancy Against Influenza-Associated Emergency Department Visits and Hospitalizations in Infants <6 Months of Age. American Journal of Obstetrics and Gynecology. 230(2). S630–S630. 1 indexed citations
3.
Burbelo, Peter D., Stephen W. Olson, Jason M. Keller, et al.. (2022). Prediagnostic Appearance of Thrombospondin Type-1 Domain 7A Autoantibodies in Membranous Nephropathy. Kidney360. 4(2). 217–225. 6 indexed citations
4.
Nee, Robert, et al.. (2021). Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination. Kidney International. 100(4). 944–945. 30 indexed citations
5.
Olson, Stephen W., et al.. (2020). Association of Race and Risk of Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis. Journal of the American Society of Nephrology. 31(10S). 65–65. 1 indexed citations
6.
Burbelo, Peter D., Meryl Waldman, Jess D. Edison, et al.. (2019). Autoantibodies are present before the clinical diagnosis of systemic sclerosis. PLoS ONE. 14(3). e0214202–e0214202. 56 indexed citations
7.
Hughes, James B., et al.. (2019). Systemic sclerosis medications and risk of scleroderma renal crisis. BMC Nephrology. 20(1). 279–279. 12 indexed citations
8.
Nee, Robert, et al.. (2019). Idiopathic Renal Infarction and Anticoagulation. SHILAP Revista de lepidopterología. 3(4). e331–e334. 5 indexed citations
9.
Nee, Robert, et al.. (2018). Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis. The Journal of Rheumatology. 46(1). 85–92. 31 indexed citations
10.
Olson, Stephen W., et al.. (2015). Longitudinal plasma metanephrines preceding pheochromocytoma diagnosis: a retrospective case–control serum repository study. European Journal of Endocrinology. 174(3). 289–295. 17 indexed citations
11.
Yuan, Christina M., et al.. (2015). Outcomes After Post-Traumatic AKI Requiring RRT in United States Military Service Members. Clinical Journal of the American Society of Nephrology. 10(10). 1732–1739. 21 indexed citations
12.
Little, Dustin J., Christina M. Yuan, John S. Thurlow, et al.. (2015). Effects of Traumatic Amputation on β-Trace Protein and β2-Microglobulin Concentrations in Male Soldiers. American Journal of Nephrology. 42(6). 436–442. 3 indexed citations
13.
Weiss, Brendan M., et al.. (2014). Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis. Journal of Clinical Oncology. 32(25). 2699–2704. 57 indexed citations
14.
Olson, Stephen W., et al.. (2013). Relation between Asymptomatic Proteinase 3 Antibodies and Future Granulomatosis with Polyangiitis. Clinical Journal of the American Society of Nephrology. 8(8). 1312–1318. 25 indexed citations
15.
Olson, Stephen W., et al.. (2013). Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 8(10). 1702–1708. 36 indexed citations
16.
Olson, Stephen W., et al.. (2011). Asymptomatic Autoantibodies Associate with Future Anti-glomerular Basement Membrane Disease. Journal of the American Society of Nephrology. 22(10). 1946–1952. 90 indexed citations
17.
Weiss, Brendan M., et al.. (2011). Monoclonal Gammopathy of Undetermined Significance (MGUS) Precedes the Diagnosis of AL Amyloidosis by up to 14 Years. Blood. 118(21). 1827–1827. 4 indexed citations
18.
Olson, Stephen W.. (2011). Toward an Integrated Science of Research on Families: Workshop Report. 14 indexed citations
19.
Perkins, Robert M., et al.. (2009). Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial. American Journal of Kidney Diseases. 53(4). 606–616. 58 indexed citations
20.
Hartzell, Joshua D., Robert Neff, Julie A. Ake, et al.. (2009). Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center. Clinical Infectious Diseases. 48(12). 1724–1728. 295 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Kwei Tsau Breakdown of academic impact, for papers by Anna Manonelles Breakdown of academic impact, for papers by E. Schulz Breakdown of academic impact, for papers by Angela Aggrey Breakdown of academic impact, for papers by Mesı̇ha Ekı̇m Breakdown of academic impact, for papers by Robert Thoburn Breakdown of academic impact, for papers by Saveria Capria Breakdown of academic impact, for papers by Francesc Fernández‐Avilés Breakdown of academic impact, for papers by Kang‐Moon Lee Breakdown of academic impact, for papers by Olivier Lortholary
Rankless by CCL
2026